Cohesinopathy

Cohesinopathy is a group of rare genetic disorders caused by mutations in genes that encode cohesin, a protein complex essential for proper chromosome segregation during cell division. Cohesin acts like a molecular glue, holding sister chromatids together from the time of DNA replication until anaphase. This ensures that each daughter cell receives an identical set of chromosomes.

When cohesin function is disrupted, chromosomes may segregate incorrectly, leading to aneuploidy, where cells have an abnormal number of chromosomes. This chromosomal instability is a hallmark of cohesinopathies and is believed to contribute to the diverse clinical features observed in affected individuals.

The clinical spectrum of cohesinopathies is broad and includes several well-defined syndromes. Cornelia de Lange syndrome (CdLS) is the most common, characterized by developmental delays, intellectual disability, distinct facial features, and limb abnormalities. Other cohesinopathies include Roberts syndrome, characterized by severe limb malformations, and various intellectual disability syndromes with overlapping features.

Diagnosis typically involves genetic testing to identify mutations in cohesin-related genes. While there is no cure for cohesinopathies, management focuses on addressing the specific symptoms and providing supportive care. Understanding the molecular mechanisms underlying cohesinopathies continues to be an active area of research, with the potential to uncover new therapeutic targets.